Clinical spectrum of cobalamin deficiency in Tunisia;Le spectre clinique des déficits en cobalamines en Tunisie

Annales de Biologie Clinique

Volumn 65, Issue 2, 2007, Pages 135-142

  Maktouf, C ^a   Bchir, F ^a   Louzir, H ^a   Elloumi, M ^b   Ben Abid, H ^c   Mdhaffer, M ^b   Elleuch, N ^d   Meddeb, B ^c   Mhiri, C ^d   Hassen, Z ^e   Makni, F ^d   Abid, M ^b   Cherif, O ^f   Rokbani, L ^f   Souissi, T ^b   Hafsia, A ^c   Dellagi, K ^a  

^a PASTEUR INSTITUTE OF TUNIS   (Tunisia)

^b HEDI CHAKER HOSPITAL   (Tunisia)

^c Hopital Aziza Othmana   (Tunisia)

^d HABIB BOURGUIBA HOSPITAL   (Tunisia)

^e RAZI HOSPITAL   (Tunisia)

^f HABIB THAMEUR HOSPITAL   (Tunisia)

Author keywords

Cobalamin deficiency; Megaloblastic anaemia; Neuro psychiatric disorder; Pernicious anaemia; Tunisia

Indexed keywords

EID: 34047128749     PISSN: 00033898     EISSN: None     Source Type: Journal    
DOI: 10.1684/abc.2007.0041     Document Type: Article

References (32)

1. Maktouf C, Bchir F, Louzir H, et al. Megaloblastic anemia in North Africa. Haematologica 2006 ; 91 : 993.
2. Friedlander RD. Racial factor in pernicious anemia. Ann Intern Med 1971 ; 74: 448.
3. Carmel R. Malabsorption of food cobalamin. Baillieres Clin Haematol 1995 ; 8 : 639-55.
4. Andres E, Affenberger S, Zimmer J, et al. Current hematological findings in cobalamin deficiency. A study of 201 consecutive patients with documented cobalamin deficiency. Clin Lab Haematol 2006 ; 28 : 50-6.
5. Metz J, Cassel R, Lewis SM. Viamin B12 and megaloblastic anaemia in South African Bantu : report of 10 cases. S Afr Med J 1958 ; 32 : 190-3.
6. Savage D, Gangaidzo I, Lindenbaum J, et al. Vitamin B12 deficiency is the primary cause of megaloblastic anaemia in Zimbabwe. Br J Haematol 1994 ; 86 : 844-50.
7. Chanarin I. The megaloblastic anaemias. Troisième édition. Oxford : Blackwell Scientific publication, 1990.
8. Maigne C. Contribution à l'étude épidé miologique de la maladie de Biermer. Thèse no 346, Lyon 1979.
9. Au WY, Hui CH, Chan LC, Liang RH, Kwong YL. Clinopathological features of megaloblastic anemia in Hong Kong : a study of 84 Chinese patients. Clin Lab Haematol 1998 ; 20 : 217-9.
10. Goldhamer SM, Bethell FH, Isaacs R, et al. The occurence and treatment of neurological changes in pernicious aneamia. JAMA 1934 ; 103 : 1667.
11. Healton EB, Savage DG, Brust JC, Garret TJ, Lindenbaum J. Neurologic aspects of cobalamin deficiency. Medecine 1991 ; 70 : 229-45.
12. Lindenbaum J, Healton EB, Savage DG, et al. Neuropsychiatric disorders caused by cobalamin deficiency in the absence of anemia or macrocytosis. N Engl J Med 1988 ; 318 : 1720-8.
13. Sari R, Ozen S, Aydogdu I, Yildrium B, Servine A. The pathological examinations of gastric mucosa in patients with Helicobacter pylori positive and negative pernicious anemia. Helicobacter 2000 ; 5 : 215-21.
14. Elsborg L, Mosbec J. Pernicious anemia as a risk factor in gastric cancer. Acta Med Scand 1979 ; 206 : 315-8.
15. Annibale B, Lahner E, Bordi C, Martino G, Caruana P. Role of Helicobacter pylori infection in pernicious anemia. Dig Liver Dis 2000 ; 32 : 756-62.
16. Karnes WE, Samloff IM, Siurala M, Kekki M, Sipponen P, Kim WR. Positive serum antibody and negative tissue staining for Helicobacter pylori in subjects with atrophic body gastritis. Gastroenterology 1991 ; 101 : 167-74.
17. Guillermo I, Pérez-Pérez GI. Role of Helibacter pylori infection in the development of penicious anemia. Clin Infect Dis 1997 ; 25 : 1020-2.
18. Karlsson FA, Burman P, Loof L, Mardah S. Major parietal cell antigen in autoimmune gastritis with pernicious anemia is the acid-producing H+,K+-adenosine triphosphatase of the stomach. J Clin Invest 1988; 81 : 475-9.
19. Gleeson PA, Toh BH. Molecular targets in pernicious anaemia. Immunol Today 1991 ; 12 : 233-8.
20. Toh BH, van Driel IR, Gleeson PA. Pernicious anemia. N Engl J Med 1997 ; 337 : 1441-8.
21. Taylor KP, Roitt IM, Doniach D, et al. Auto-immune phenomena in anemia : gastric antibodies. Br Med J 1962 ; 2 : 1347-52.
22. Chanarin I. Penicious anemia as an auto-immune disease. Br J Hem 1972 ; 23 : 101-7.
23. Carmel R. Reassessment of the relative prevalences of antibodies to gastric parietal cell and to intrinsic factor in patients with pernicious anaemia : influence of patient age and race. Clin Exp Immunol 1992 ; 89 : 74-7.
24. Muller HK, McGiven AR, Nairn RC. Immunofluorescent staining of rat gastric parietal cells by human antibody unrelated to pernicious anaemia. J Clin Pathol 1971 ; 24 : 13-4.
25. Stikland RG, Hopper B. The parietal cell heteroantibody in human sera : prevalence in normal population and relationship to parietal cell autoantibody. Pathology 1972 ; 4 : 259-63.
26. Doniach D, Roitt IM, Taylor KB. Autoimmune phenomena in pernicious anemia. Seological overlap with thyroiditis, thyreotoxicosis and systemic lupus erythematosus. Br Med J 1963 : 1374-9.
27. Durston JH. Myasthenia gravis, Hashimoto's disease and pernicious anemia. Postgrad Med J 1969 ; 45 : 290-1.
28. Zittoun R, Zittoun J, Arrago JP, et al. Maladie de Biermer sans anémie ni mégaloblastose. Ann Med Interne (Paris) 1983 ; 134 : 569-72.
29. Bouchlaka C, Maktouf C, Braham M, et al. Genetic heterogeneity of megaloblastic anemia type 1 in Tunisian patients. Hum Genet 2007 ; sous presse.
30. Allen RH, Stabler SP, Savage D, Lindenbaum J. Diagnosis of cobalamin deficiency. I. Usefulness of serum methylmalonic acid and total homocysteine concentrations. Am J Hematol 1990 ; 34 : 90.
31. Carmel R. Current concepts in cobalamin deficiency. Annu Rev Med 2000; 51 : 357-75.
32. Hvas AM. Diagnosis and treatment of vitamin B12 deficiency -an update. Haematologica 2006 ; 91 : 1508-14.